, November 2022 — Base-editing-mediated dissection of a \gamma-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nature Communications vol. 13, n° 1, dir. {Nature Publishing Group} p. 6618
, June 2022 — Disease modeling by efficient genome editing using a near PAM-less base editor in vivo. Nature Communications vol. 13, n° 1, dir. {Nature Publishing Group} p. 3435
, 2022 — CRISPR gene editing in pluripotent stem cells reveals the function of MBNL proteins during human in vitro myogenesis. Human Molecular Genetics vol. 31, n° 1, dir. {Oxford University Press (OUP)} p. 41-56
, December 2021 — « Tagging Proteins with Fluorescent Reporters Using the CRISPR/Cas9 System and Double-Stranded DNA Donors » in Multiprotein Complexes.. , , p. 39-57
, October 2021 — Recent Progress in Genome Editing for Gene Therapy Applications: The French Perspective. Human Gene Therapy vol. 32, 19-20, dir. {Mary Ann Liebert} p. 1059-1075
, March 2021 — Correction of \beta-thalassemia by CRISPR/Cas9 editing of the \alpha-globin locus in human hematopoietic stem cells. Blood Advances vol. 5, n° 5, dir. {The American Society of Hematology} p. 1137-1153
, March 2021 — Precise base editing for the in vivo study of developmental signaling and human pathologies in zebrafish. eLife vol. 10, , dir. {eLife Sciences Publication}
, 2021 — Gene Tagging with the CRISPR-Cas9 System to Facilitate Macromolecular Complex Purification. Methods in molecular biology (Clifton, N.J.) vol. 2305, , p. 153-174
, July 2020 — Characterization of post-edited cells modified in the TFAM gene by CRISPR/Cas9 technology in the bovine model. PLoS ONE vol. 15, n° 7, dir. {Public Library of Science} e0235856
, July 2020 — Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Nature Communications vol. 11, n° 1, dir. {Nature Publishing Group} p. 3778
, March 2020 — Expression analysis data of BCL11A and \gamma-globin genes in KU812 and KG-1 cell lines after CRISPR/Cas9-mediated BCL11A enhancer deletion. Data in Brief vol. 28, , dir. {Elsevier} p. 104974
, March 2020 — Editing a \gamma-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype. Science Advances vol. 6, n° 7, dir. {American Association for the Advancement of Science (AAAS)} eaay9392
, January 2020 — Heat Shock Factor 2 Protects against Proteotoxicity by Maintaining Cell-Cell Adhesion. Cell Reports vol. 30, n° 2, dir. {Elsevier Inc} 583-597.e6
, December 2019 — Functional interplay between TFIIH and KAT2A regulates higher-order chromatin structure and class II gene expression. Nature Communications vol. 10, n° 1, dir. {Nature Publishing Group} p. 1288
, November 2019 — Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9. Animal Model Exp Med / Animal models and experimental medicine. vol. 2, n° 4, dir. {[Hoboken, New Jersey] : John Wiley \& Sons, Inc., [2018]-} p. 297-311
, August 2019 — Identification of the master sex determining gene in Northern pike (Esox lucius) reveals restricted sex chromosome differentiation. PLoS Genetics vol. 15, n° 8, dir. {Public Library of Science} e1008013
, July 2019 — Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease. European Journal of Pharmacology vol. 854, , dir. {Elsevier} p. 398-405
, March 2019 — Edition of TFAM gene by CRISPR/Cas9 technology in bovine model. PLoS ONE vol. 14, n° 3, dir. {Public Library of Science} e0213376
, 2019 — Differential Requirements for the RAD51 Paralogs in Genome Repair and Maintenance in Human Cells. PLoS Genetics vol. 15, n° 10, dir. {Public Library of Science} e1008355
, December 2018 — High doses of CRISPR/Cas9 ribonucleoprotein efficiently induce gene knockout with low mosaicism in the hydrozoan Clytia hemisphaerica through microhomology-mediated deletion. Scientific Reports vol. 8, n° 1, dir. {Nature Publishing Group}